Named on one round in the feed.
Since 2025-02-26
ROUNDS
1
joined, none as lead
ROUNDS JOINED · USD
$350.7M
across 1 round
CO-INVESTORS
9
named beside it
Named on one round in the feed.
Since 2025-02-26
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Eikon Therapeutics Eikon is a late-stage clinical biopharmaceutical company focused on inventing and developing breakthrough therapeutics for serious illnesses through innovative scientific and engineering approaches. | Series D Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $350.7M | 2025-02-26 | [ PART ] |
No sector on record.